Brent Blackburn

Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial

Ami E. Iskandrian, Timothy M. Bateman, Luiz Belardinelli et al. · Journal of Nuclear Cardiology · 2007 · 345 citations

Medicine, Cardiology, Radiology +17

Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure

Hani N. Sabbah, Margaret P. Chandler, Takayuki Mishima et al. · Journal of Cardiac Failure · 2002 · 142 citations

Medicine, Cardiology, Pharmacology +15

Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans

Hsiao D. Lieu, John C. Shryock, Gregory O. von Mering et al. · Journal of Nuclear Cardiology · 2007 · 139 citations

Medicine, Cardiology, Pharmacology +11

Short-Term Treatment With Ranolazine Improves Mechanical Efficiency in Dogs With Chronic Heart Failure

Margaret P. Chandler, William C. Stanley, Hideaki Morita et al. · Circulation Research · 2002 · 139 citations

Medicine, Cardiology, Pharmacology +14

Initial Clinical Experience With Regadenoson, a Novel Selective A2AAgonist for Pharmacologic Stress Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging

Robert C. Hendel, Timothy M. Bateman, Manuel D. Cerqueira et al. · Journal of the American College of Cardiology · 2005 · 128 citations

Medicine, Pharmacology, Radiology +14